MedTrace Logo

PS IVG : Psychosocial Determinants of Late-term Abortions (14-16 Weeks' Gestation) at Avignon Hospital

NCT07650071 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-06-16

No results posted yet for this study

Summary

Abortion is a fundamental right for women in France, where the legal time limit was extended from 14 to 16 weeks' gestation. This extension allows women, whose psychosocial determinants are poorly known, and who face various obstacles (personal, administrative, medical, or other), to access abortion. However, it may also expose them to psychological troubles and difficulties in accessing healthcare. This study aims to identify the psychosocial determinants and disruptions in the primary care pathway associated with late abortions (≥14 weeks' gestation \[WG\]) in order to propose preventive actions, particularly regarding contraception, screening, and referral, directly applicable in general practice.

Conditions

  • Psychosocial Health
  • Abortion

Interventions

BEHAVIORAL

Health survey

It consists of a single anonymous questionnaire, to be completed once only, on a secure online platform, accessed using a QR code provided directly by the healthcare professional. The questionnaire consists of 39 main questions, predominantly with closed-ended response options. The average completion time is estimated between 10 and 20 minutes.

Sponsors & Collaborators

  • Centre Hospitalier Henri Duffaut - Avignon

    lead OTHER

Principal Investigators

  • Perrine Mazet, MD · Centre Hospitalier d'Avignon, Service de Gynécologie

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2027-06-15
Completion
2027-09-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07650071 on ClinicalTrials.gov